Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × avelumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 27 Carcinoma, Transitional Cell 25 Urinary Bladder Neoplasms 23 Neoplasms 20 Carcinoma, Merkel Cell 20 Carcinoma, Renal Cell 18 Neoplasm Metastasis 17 Colorectal Neoplasms 15 Breast Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 12 Ovarian Neoplasms 12 Triple Negative Breast Neoplasms 8 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Stomach Neoplasms 6 Melanoma 6 Recurrence 5 Prostatic Neoplasms 5 Carcinoma, Hepatocellular 5 Ureteral Neoplasms 4 Small Cell Lung Carcinoma 4 Neuroendocrine Tumors 4 Glioblastoma 4 Carcinoma, Squamous Cell 4 Uterine Cervical Neoplasms 3 Urethral Neoplasms 3 Turcot syndrome 3 Skin Neoplasms 3 Sarcoma 3 Lymphoma 3

Interventions

Rituximab 97 Cyclophosphamide 93 fludarabine 56 Doxorubicin 29 Vincristine 27 Prednisone 27 Etoposide 25 Lenalidomide 22 ibrutinib 20 fludarabine phosphate 20 obinutuzumab 16 pembrolizumab 15 Bendamustine Hydrochloride 15 Magnetic Resonance Spectroscopy 14 Immunotherapy, Adoptive 14 Cytarabine 13 Specimen Handling 11 CT-P10 11 Bortezomib 11 polatuzumab vedotin 10 Gemcitabine 10 venetoclax 9 pirtobrutinib 9 Nivolumab 9 Carboplatin 9 Biopsy 9 zanubrutinib 8 glofitamab 8 Radiotherapy 8 Ifosfamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡